Takeda Oncology

Home
Takeda Oncology

We aspire to cure cancer, with inspiration from patients and innovation from everywhere. At Takeda, we are united by our aspiration to cure cancer.

Takeda Oncology is the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited. Drawing on decades of leadership in oncology, we strive to develop innovative treatments that make a difference in the lives of people with cancer. Our research and development efforts are focused on advancing medicines for thoracic, gastrointestinal and hematologic cancers by leveraging modalities best suited to treat these diseases. Our global in-house expertise and innovation are complemented by our valued partners. We fuel these relationships with respect, scientific rigor and a shared commitment to address the most urgent needs of patients. Our diverse global team fosters an inclusive environment where employees are welcomed, empowered and inspired. We are committed to ensuring that patients globally can benefit from and access our portfolio of medicines, while also progressing a pipeline of potential treatments for the future. For more information, visit www.takedaoncology.com. Review our social media community guidelines: https://www.takedaoncology.com/social-media-policy/.

02/09/2025

At 31, Jenna faced the daunting realities of a metastatic colorectal cancer ( ) diagnosis.

For those encountering similar challenges, her story stands as a powerful testament to resilience and the remarkable support found within the mCRC community.

Learn more about Jenna’s journey at http://www.UnderstandingmCRC.com.

This website, built on insights from real patients, like Jenna, aims to offer tools for those affected by mCRC.

20/08/2025

Inspired by a high school teacher, Minakshi Guha, a scientist at Takeda Oncology, has turned her early passion for into a career dedicated to advancing treatment.

Learn more about our science: https://www.takedaoncology.com/science/

13/08/2025

Minakshi Guha, a scientist at Takeda Oncology, is on a mission to utilize ctDNA to match the right treatment to the right patient at the right time. Discover what ctDNA is and how it could potentially transform the cancer treatment experience for patients.

Learn more about our science: https://www.takedaoncology.com/science/

07/08/2025

Our riders brought incredible energy to this year’s Pan-Mass Challenge, cycling for a cure and supporting vital cancer research. We’re proud of their dedication in helping advance treatments for people battling cancer. Please join us in recognizing their impact!

06/08/2025

Progress is fueled by passionate innovators like one of our scientists, Minakshi. Watch her discuss an advanced treatment monitoring and response protocol for people living with known as liquid biopsy.

Learn more: https://www.takedaoncology.com/science/

09/07/2025

To ensure patients’ needs are met, we are committed to understanding the perspectives of the metastatic colorectal cancer ( ) community across the globe. Read the results from our Europe and Canada-based patient survey presented at : https://cslide.ctimeetingtech.com/coasis_21393/attendee/confcal/presentation/list?q=68P

07/07/2025

As we reflect on ALK Positive Awareness Month, we want to shine a light on inspiring individuals making a difference in their community. One of those individuals is Summer – a wife, mother and advocate living with ALK+ non-small cell . Read her perspective on self-advocacy and explore available care resources by heading to https://www.takedaoncology.com/patients/resources/

19/03/2025

On , we were reminded how blue represents the color of hope, resilience and progress. This and beyond, let’s continue to come together, support those affected by CRC and inspire hope for a brighter future.

10/03/2025

Everyone in the (CRC) community needs a strong network of support during diagnosis, treatment and beyond.

For , we asked advocates to share their perspectives on navigating a metastatic colorectal cancer ( ) diagnosis and treatment. Swipe to see their thoughts on empowerment, self-advocacy, and how patient advocacy groups can support.

07/02/2025

For patients living with metastatic colorectal cancer ( ), having a voice in your own care is key to shaping your cancer journey.

Our U.S. patient survey conducted in collaboration with advocacy partners, BLKHLTH, Family Reach, Colontown - Here With You. and Colorectal Cancer Alliance, shined a light on the factors impacting mCRC treatment decisions. Read the results presented at the ASCO GI Symposium: https://meetings.asco.org/abstracts-presentations/241929

Thank you to our advocacy partners and our Head of Patient Advocacy and Engagement, Scott Campbell, for your dedication to mCRC patients.

04/02/2025

This World Cancer Day, we join the global community to highlight the importance of seeing and treating the whole person and not just the disease. We believe that cancer care is more than medicine. Join the community by sharing this post to raise awareness of .

03/02/2025

Navigating a metastatic colorectal cancer ( ) diagnosis can be overwhelming, especially when making treatment decisions.

New data from our U.S. patient survey done in collaboration with BLKHLTH, Family Reach, COLONTOWN and Colorectal Cancer Alliance revealed different factors, many of which disproportionally impact Black and Hispanic communities.

Read the results presented at the American Society of Clinical Oncology (ASCO)’s Gastrointestinal Symposium here: https://meetings.asco.org/abstracts-presentations/241929

Address

Telephone

+18668352233

Website

http://www.takedaoncology.com/

Alerts

Be the first to know and let us send you an email when Takeda Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Takeda Oncology:

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City:

Our Story

No two people with cancer are alike. Each individual patient’s circumstances, concerns, struggles and successes are as unique as their needs. The strength and bravery of these individuals inspire and compel us every day. Delivering on the unique needs of each person with cancer has been at the core of our oncology business since our inception, and it remains at the very heart of our commitment, research and outreach.

Our mission remains constant — we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients.

We are working every day to achieve our aspiration to cure cancer. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, we are finding innovative ways to improve the treatment of cancer.